China Resources Boya Bio pharmaceutical Group Co Ltd
SZSE:300294

Watchlist Manager
China Resources Boya Bio pharmaceutical Group Co Ltd Logo
China Resources Boya Bio pharmaceutical Group Co Ltd
SZSE:300294
Watchlist
Price: 23.17 CNY 0.74% Market Closed
Market Cap: ¥11.7B

Wall Street
Price Targets

Price Targets Summary
China Resources Boya Bio pharmaceutical Group Co Ltd

Wall Street analysts forecast China Resources Boya Bio pharmaceutical Group Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for China Resources Boya Bio pharmaceutical Group Co Ltd is 31.78 CNY with a low forecast of 28.28 CNY and a high forecast of 36.75 CNY.

Lowest
Price Target
28.28 CNY
22% Upside
Average
Price Target
31.78 CNY
37% Upside
Highest
Price Target
36.75 CNY
59% Upside
China Resources Boya Bio pharmaceutical Group Co Ltd Competitors:
Price Targets
FSFG
First Savings Financial Group Inc
2% Upside
MTRX
Matrix Service Co
23% Upside
AFYA
Afya Ltd
27% Upside
0HQ1
Brooks Automation Inc
-2% Downside
TCPC
BlackRock TCP Capital Corp
13% Upside
NYXH
Nyxoah SA
119% Upside

Revenue
Forecast

18% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss
18% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss

For the last 13 years the compound annual growth rate for China Resources Boya Bio pharmaceutical Group Co Ltd's revenue is 18%. The projected CAGR for the next 3 years is 12%.

Operating Income
Forecast

15% / Year
Past Growth
26% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss
15% / Year
Past Growth
26% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss

For the last 13 years the compound annual growth rate for China Resources Boya Bio pharmaceutical Group Co Ltd's operating income is 15%. The projected CAGR for the next 4 years is 26%.

Net Income
Forecast

15% / Year
Past Growth
20% / Year
Estimated Growth
Estimates Accuracy
-26%
Average Miss
15% / Year
Past Growth
20% / Year
Estimated Growth
Estimates Accuracy
-26%
Average Miss

For the last 13 years the compound annual growth rate for China Resources Boya Bio pharmaceutical Group Co Ltd's net income is 15%. The projected CAGR for the next 3 years is 20%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is China Resources Boya Bio pharmaceutical Group Co Ltd's stock price target?
Price Target
31.78 CNY

According to Wall Street analysts, the average 1-year price target for China Resources Boya Bio pharmaceutical Group Co Ltd is 31.78 CNY with a low forecast of 28.28 CNY and a high forecast of 36.75 CNY.

What is China Resources Boya Bio pharmaceutical Group Co Ltd's Revenue forecast?
Projected CAGR
12%

For the last 13 years the compound annual growth rate for China Resources Boya Bio pharmaceutical Group Co Ltd's revenue is 18%. The projected CAGR for the next 3 years is 12%.

What is China Resources Boya Bio pharmaceutical Group Co Ltd's Operating Income forecast?
Projected CAGR
26%

For the last 13 years the compound annual growth rate for China Resources Boya Bio pharmaceutical Group Co Ltd's operating income is 15%. The projected CAGR for the next 4 years is 26%.

What is China Resources Boya Bio pharmaceutical Group Co Ltd's Net Income forecast?
Projected CAGR
20%

For the last 13 years the compound annual growth rate for China Resources Boya Bio pharmaceutical Group Co Ltd's net income is 15%. The projected CAGR for the next 3 years is 20%.

Back to Top